The Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.

NCT ID: NCT04886752

Last Updated: 2021-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-10

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the difference between vitamin C in the form of oral liposomes and general vitamin C in a fixed period of time in plasma and urine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

we recruited 11 healthy subjects and adopted a cross-over test. the subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start. The subjects were informed to consume one sachet vitamin C without liposome, liposomal process A vitamin C, or liposomal process B vitamin C (Double Nutri™) every test, and vitamin C concentration was measured at baseline (0 hours), 0.5, 1, 2, 3, 4, and 8 hours after taking test sample.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vitamin C Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

vitamin C without liposome

vitamin C without liposome

Group Type SHAM_COMPARATOR

vitamin C without liposome

Intervention Type DIETARY_SUPPLEMENT

subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start

liposomal process A vitamin C

liposomal process A vitamin C

Group Type PLACEBO_COMPARATOR

liposomal process A vitamin C

Intervention Type DIETARY_SUPPLEMENT

subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start

liposomal process B vitamin C (Double Nutri™)

liposomal process B vitamin C (Double Nutri™)

Group Type EXPERIMENTAL

liposomal process B vitamin C (Double Nutri™)

Intervention Type DIETARY_SUPPLEMENT

subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

vitamin C without liposome

subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start

Intervention Type DIETARY_SUPPLEMENT

liposomal process A vitamin C

subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start

Intervention Type DIETARY_SUPPLEMENT

liposomal process B vitamin C (Double Nutri™)

subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adults between 20-60 years old,
2. No heart, liver, kidney, endocrine and major organic diseases

Exclusion Criteria

1. Renal insufficiency and dialysis
2. Cancer
3. Underweight (BMI≦17) or obese (BMI≧27),
4. Take chronic disease drugs,
5. Blood pressure systolic blood pressure ≧130 mmHg or diastolic blood pressure ≧85 mmHg,
6. Too high fasting blood glucose ≧ 100 mg/dL,
7. Triglyceride ≧ 150 mg/dL,Total cholesterol ≧ 200 mg/dL,
8. Have a history of vitamin C allergy,
9. People with mental illness,
10. Pregnant or breastfeeding women,
11. Hematosis,
12. Kidney stones,
13. Long-term vitamin C supplements (at least 200 mg per day for more than one month)
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TCI Co., Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaw-Shiun Tsai, Doctor

Role: PRINCIPAL_INVESTIGATOR

National Taiwan University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research & Design Center, TCI CO., Ltd

Taipei, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201903113RSA

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.